Cargando…

Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial

BACKGROUND: Prevention and optimal treatment of postoperative bleeding are of great clinical importance in various types of surgeries including coronary artery bypass graft (CABG). Reducing the amount of bleeding will reduce the complications subsequent to blood transfusion. The positive effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Javaherforoosh Zadeh, Fatemeh, Janatmakan, Farahzad, Soltanzadeh, Mansoor, Zamankhani, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825327/
https://www.ncbi.nlm.nih.gov/pubmed/31754609
http://dx.doi.org/10.5812/aapm.92165
_version_ 1783464877077037056
author Javaherforoosh Zadeh, Fatemeh
Janatmakan, Farahzad
Soltanzadeh, Mansoor
Zamankhani, Maryam
author_facet Javaherforoosh Zadeh, Fatemeh
Janatmakan, Farahzad
Soltanzadeh, Mansoor
Zamankhani, Maryam
author_sort Javaherforoosh Zadeh, Fatemeh
collection PubMed
description BACKGROUND: Prevention and optimal treatment of postoperative bleeding are of great clinical importance in various types of surgeries including coronary artery bypass graft (CABG). Reducing the amount of bleeding will reduce the complications subsequent to blood transfusion. The positive effects of coagulation factors, especially fibrinogen, after cardiovascular bypass could have beneficial effects due to reduced bleeding and less need for blood transfusion. However, different studies have reported controversial findings. OBJECTIVES: The present study aimed to evaluate the effect of prophylactic administration of fibrinogen on blood loss in patients undergoing CABG surgery to achieve more accurate clinical outcomes. METHODS: This was a double-blind randomized clinical trial conducted on 36 patients hospitalized in Ahvaz Imam Khomeini Hospital for coronary artery bypass graft. Patients were randomized to receive either fibrinogen concentrate (n = 18) or placebo (n = 18). Hemoglobin, hematocrit, international normalized ratio, prothrombin time, partial thromboplastin time, and fibrinogen were checked preoperatively. The transfusion of allogeneic blood components and the volume of blood loss were recorded and compared between the groups. RESULTS: Prophylactic fibrinogen injection reduced the need for blood transfusion, blood products, and postoperative hypotension in the fibrinogen group when compared to the control group (P ≤ 0.005). There was a significant difference between the two groups in terms of the amount of bleeding during operation (P ≤ 0.005). CONCLUSIONS: Fibrinogen plays a key role in preventing and stopping the bleeding. Accordingly, fibrinogen decreases bleeding and the need for paced cell in patients in CABG. Given the adverse outcomes of bleeding and coagulopathy in patients undergoing surgery, we conclude that the use of fibrinogen could be beneficial as a prophylactic in hemorrhagic surgery.
format Online
Article
Text
id pubmed-6825327
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-68253272019-11-21 Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial Javaherforoosh Zadeh, Fatemeh Janatmakan, Farahzad Soltanzadeh, Mansoor Zamankhani, Maryam Anesth Pain Med Research Article BACKGROUND: Prevention and optimal treatment of postoperative bleeding are of great clinical importance in various types of surgeries including coronary artery bypass graft (CABG). Reducing the amount of bleeding will reduce the complications subsequent to blood transfusion. The positive effects of coagulation factors, especially fibrinogen, after cardiovascular bypass could have beneficial effects due to reduced bleeding and less need for blood transfusion. However, different studies have reported controversial findings. OBJECTIVES: The present study aimed to evaluate the effect of prophylactic administration of fibrinogen on blood loss in patients undergoing CABG surgery to achieve more accurate clinical outcomes. METHODS: This was a double-blind randomized clinical trial conducted on 36 patients hospitalized in Ahvaz Imam Khomeini Hospital for coronary artery bypass graft. Patients were randomized to receive either fibrinogen concentrate (n = 18) or placebo (n = 18). Hemoglobin, hematocrit, international normalized ratio, prothrombin time, partial thromboplastin time, and fibrinogen were checked preoperatively. The transfusion of allogeneic blood components and the volume of blood loss were recorded and compared between the groups. RESULTS: Prophylactic fibrinogen injection reduced the need for blood transfusion, blood products, and postoperative hypotension in the fibrinogen group when compared to the control group (P ≤ 0.005). There was a significant difference between the two groups in terms of the amount of bleeding during operation (P ≤ 0.005). CONCLUSIONS: Fibrinogen plays a key role in preventing and stopping the bleeding. Accordingly, fibrinogen decreases bleeding and the need for paced cell in patients in CABG. Given the adverse outcomes of bleeding and coagulopathy in patients undergoing surgery, we conclude that the use of fibrinogen could be beneficial as a prophylactic in hemorrhagic surgery. Kowsar 2019-08-27 /pmc/articles/PMC6825327/ /pubmed/31754609 http://dx.doi.org/10.5812/aapm.92165 Text en Copyright © 2019, Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Javaherforoosh Zadeh, Fatemeh
Janatmakan, Farahzad
Soltanzadeh, Mansoor
Zamankhani, Maryam
Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial
title Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial
title_full Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial
title_fullStr Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial
title_full_unstemmed Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial
title_short Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial
title_sort investigating the effect of fibrinogen injection on bleeding in coronary artery bypass surgery: a clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825327/
https://www.ncbi.nlm.nih.gov/pubmed/31754609
http://dx.doi.org/10.5812/aapm.92165
work_keys_str_mv AT javaherforooshzadehfatemeh investigatingtheeffectoffibrinogeninjectiononbleedingincoronaryarterybypasssurgeryaclinicaltrial
AT janatmakanfarahzad investigatingtheeffectoffibrinogeninjectiononbleedingincoronaryarterybypasssurgeryaclinicaltrial
AT soltanzadehmansoor investigatingtheeffectoffibrinogeninjectiononbleedingincoronaryarterybypasssurgeryaclinicaltrial
AT zamankhanimaryam investigatingtheeffectoffibrinogeninjectiononbleedingincoronaryarterybypasssurgeryaclinicaltrial